MorphoSys AG buy Vassago1
Start price
21.11.23
/
50%
€17.65
Target price
21.11.24
€65.00
Performance (%)
281.87%
End price
22.11.24
-
Summary
This prediction is currently being closed. The BUY prediction by Vassago1 for MorphoSys AG has seen massive gains of 281.87%. Vassago1 has 50% into this predictionMorphoSys is a German biopharmaceutical company that develops innovative therapies for the treatment of cancer, autoimmune diseases, and other serious illnesses. The company specializes in developing monoclonal antibodies, which are highly specific and targeted therapies that recognize and bind to specific cancer cells or disease-causing proteins in the body. MorphoSys has a diverse pipeline of products in various stages of development, including several drugs that have shown promising results in clinical trials. The company is listed on the Frankfurt and NASDAQ stock exchanges and has a market capitalization of over $4 billion.
Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| MorphoSys AG | - | - | - |
| iShares Core DAX® | 0.734% | -0.964% | 17.910% |
| iShares Nasdaq 100 | -2.686% | -2.409% | 4.267% |
| iShares Nikkei 225® | -2.261% | -4.038% | 10.420% |
| iShares S&P 500 | -1.346% | -1.510% | 1.615% |
Comments by Vassago1 for this prediction
In the thread Morphosys AG diskutieren
Buy MorphoSys AG
Kursziel gesetzt auf 65,0
In the thread Trading Morphosys AG
Die von Vassago1 gewählte maximale Laufzeit wurde überschritten